Compressus bolsters executive team

TriMed Staff | | Health Imaging | Artificial Intelligence

Compressus has promoted Janine Broda to chief marketing officer and appointed Shawn Gibbons as corporate executive vice president (VP) and general manager of its MEDxConnect division.

Previously serving as VP and general manager of the MEDxConnect division, Broda is now responsible for market positioning for Compressus' medical imaging products. Gibbons' will be responsible for managing the continued expansion of the MEDxConnect sales, marketing and customer support operations, according to John B. Macfarlane, CEO, Compressus.

Prior to joining Compressus, Broda was the VP of professional services and director of sales for the Western region of Fischer Imaging. Prior to that, Broda spent 18 years at Agfa HealthCare, starting as a sales executive and eventually becoming director of strategic business development.

A 25-year veteran of the PACS, healthcare information systems and radiology industries, Gibbons previously served as global PACS product manager for GE Healthcare IITS. Prior to GE, he was at IDX, where he served as imaging-integration product manager, responsible for the new product launches, development of a cardiology PACS product line and the overall product roadmap.

 

TriMed Staff

Related Content

Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.